UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 177

Sortiert nach

Rac1 activates non-oxidative pentose phosphate pathway to induce chemoresistance of breast cancer

Nature communications, 2020-03, Vol.11 (1), p.1456-18, Article 1456

2020

Link zum Volltext

Verfügbarkeit prüfen

CD10+GPR77+ Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness

Cell, 2018-02, Vol.172 (4), p.841-856.e16

2018

Link zum Volltext

Verfügbarkeit prüfen

Fusobacterium and Colorectal Cancer

Frontiers in oncology, 2018-10, Vol.8, p.371-371

2018

Link zum Volltext

Verfügbarkeit prüfen

The HIF-1α antisense long non-coding RNA drives a positive feedback loop of HIF-1α mediated transactivation and glycolysis

Nature communications, 2021-02, Vol.12 (1), p.1341-1341, Article 1341

2021

Link zum Volltext

Verfügbarkeit prüfen

LncRNA PVT1 triggers Cyto-protective autophagy and promotes pancreatic ductal adenocarcinoma development via the miR-20a-5p/ULK1 Axis

Molecular cancer, 2018-07, Vol.17 (1), p.98-98

2018

Link zum Volltext

Verfügbarkeit prüfen

Up-regulation of miR-21 Mediates Resistance to Trastuzumab Therapy for Breast Cancer

The Journal of biological chemistry, 2011-05, Vol.286 (21), p.19127-19137

2011

Link zum Volltext

Verfügbarkeit prüfen

miR-142-5p and miR-130a-3p are regulated by IL-4 and IL-13 and control profibrogenic macrophage program

Nature communications, 2015-10, Vol.6 (1), p.8523-8523, Article 8523

2015

Link zum Volltext

Verfügbarkeit prüfen

Tumor-Associated Macrophages Promote Malignant Progression of Breast Phyllodes Tumors by Inducing Myofibroblast Differentiation

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13), p.3605-3618

2017

Link zum Volltext

Verfügbarkeit prüfen

Targeting regulator of G protein signaling 1 in tumor-specific T cells enhances their trafficking to breast cancer

Nature immunology, 2021-07, Vol.22 (7), p.865

2021

Link zum Volltext

Verfügbarkeit prüfen

Multicenter phase II trial of Camrelizumab combined with Apatinib and Eribulin in heavily pretreated patients with advanced triple-negative breast cancer

Nature communications, 2022-05, Vol.13 (1), p.3011-10, Article 3011

2022

Link zum Volltext

Verfügbarkeit prüfen

CCL18 from Tumor-Associated Macrophages Promotes Breast Cancer Metastasis via PITPNM3

Cancer cell, 2011-04, Vol.19 (4), p.541-555

2011

Link zum Volltext

Verfügbarkeit prüfen

NKILA represses nasopharyngeal carcinoma carcinogenesis and metastasis by NF-κB pathway inhibition

PLoS genetics, 2019-08, Vol.15 (8), p.e1008325

2019

Link zum Volltext

Verfügbarkeit prüfen

Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1

Nature communications, 2018-04, Vol.9 (1), p.1595-11, Article 1595

2018

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of camrelizumab combined with apatinib in advanced triple-negative breast cancer: an open-label phase II trial

Journal for immunotherapy of cancer, 2020-05, Vol.8 (1), p.e000696

2020

Link zum Volltext

Verfügbarkeit prüfen

A serum microRNA signature predicts trastuzumab benefit in HER2-positive metastatic breast cancer patients

Nature communications, 2018-04, Vol.9 (1), p.1614-13, Article 1614

2018

Link zum Volltext

Verfügbarkeit prüfen

Reduced miR-128 in Breast Tumor-Initiating Cells Induces Chemotherapeutic Resistance via Bmi-1 and ABCC5

Clinical cancer research, 2011-11, Vol.17 (22), p.7105-7115

2011

Link zum Volltext

Verfügbarkeit prüfen

Enhancer-Driven lncRNA BDNF-AS Induces Endocrine Resistance and Malignant Progression of Breast Cancer through the RNH1/TRIM21/mTOR Cascade

Cell reports (Cambridge), 2020-06, Vol.31 (10), p.107753-107753, Article 107753

2020

Link zum Volltext

Verfügbarkeit prüfen

Long noncoding RNA HOTAIR is a prognostic marker for esophageal squamous cell carcinoma progression and survival

PloS one, 2013-05, Vol.8 (5), p.e63516-e63516

2013

Link zum Volltext

Verfügbarkeit prüfen

MiR-196a promotes pancreatic cancer progression by targeting nuclear factor kappa-B-inhibitor alpha

PloS one, 2014-02, Vol.9 (2), p.e87897-e87897

2014

Link zum Volltext

Verfügbarkeit prüfen

Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter study

EBioMedicine, 2021-07, Vol.69, p.103460-103460, Article 103460

2021

Link zum Volltext

Verfügbarkeit prüfen

Impact of body mass index and its change on survival outcomes in patients with early breast cancer: A pooled analysis of individual-level data from BCIRG-001 and BCIRG-005 trials

Breast (Edinburgh), 2023-10, Vol.71, p.1-12

2023

Link zum Volltext

Verfügbarkeit prüfen

Overexpressed Cyclin D1 and CDK4 proteins are responsible for the resistance to CDK4/6 inhibitor in breast cancer that can be reversed by PI3K/mTOR inhibitors

Science China. Life sciences, 2023, Vol.66 (1), p.94-109

2023

Link zum Volltext

Verfügbarkeit prüfen

Landscape of somatic alterations in large-scale solid tumors from an Asian population

Nature communications, 2022-07, Vol.13 (1), p.4264-4264, Article 4264

2022

Link zum Volltext

Verfügbarkeit prüfen

Distinct ER and PR expression patterns significantly affect the clinical outcomes of early HER2-positive breast cancer: A real-world analysis of 871 patients treated with neoadjuvant therapy

Breast (Edinburgh), 2024-06, Vol.75, p.103733-103733, Article 103733

2024

Link zum Volltext

Verfügbarkeit prüfen

The Overexpression of Hypomethylated miR-663 Induces Chemotherapy Resistance in Human Breast Cancer Cells by Targeting Heparin Sulfate Proteoglycan 2 (HSPG2)

The Journal of biological chemistry, 2013-04, Vol.288 (16), p.10973-10985

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 177

Suche als RSS-Feed

Aktive Filter

KollektionSpringerLINK Contemporary (Konsortium Baden-Württemberg)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(162)
Mit Volltextzugriff
(169)

Publikationsform

Artikel
(176)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(108)
Life Sciences & Biomedicine
(85)
Oncology
(56)
Humans
(53)
Breast Cancer
(48)
Female
(46)
Cancer
(30)
Metastasis
(28)
Breast Neoplasms - Pathology
(25)
Middle Aged
(24)
Cell Line, Tumor
(23)
Tumors
(22)
Adult
(20)
Breast Neoplasms - Genetics
(19)
Medical Prognosis
(19)
Science & Technology - Other Topics
(19)
Multidisciplinary Sciences
(17)
Animals
(16)
Chemotherapy
(15)
Immunotherapy
(15)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Rac1 activates non-oxidative pentose phosphate pathway to induce chemoresistance of breast cancer

CD10+GPR77+ Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness

Fusobacterium and Colorectal Cancer

The HIF-1α antisense long non-coding RNA drives a positive feedback loop of HIF-1α mediated transactivation and glycolysis

LncRNA PVT1 triggers Cyto-protective autophagy and promotes pancreatic ductal adenocarcinoma development via the miR-20a-5p/ULK1 Axis

Up-regulation of miR-21 Mediates Resistance to Trastuzumab Therapy for Breast Cancer

miR-142-5p and miR-130a-3p are regulated by IL-4 and IL-13 and control profibrogenic macrophage program

Tumor-Associated Macrophages Promote Malignant Progression of Breast Phyllodes Tumors by Inducing Myofibroblast Differentiation

Targeting regulator of G protein signaling 1 in tumor-specific T cells enhances their trafficking to breast cancer

Multicenter phase II trial of Camrelizumab combined with Apatinib and Eribulin in heavily pretreated patients with advanced triple-negative breast cancer

CCL18 from Tumor-Associated Macrophages Promotes Breast Cancer Metastasis via PITPNM3

NKILA represses nasopharyngeal carcinoma carcinogenesis and metastasis by NF-κB pathway inhibition

Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1

Efficacy and safety of camrelizumab combined with apatinib in advanced triple-negative breast cancer: an open-label phase II trial

A serum microRNA signature predicts trastuzumab benefit in HER2-positive metastatic breast cancer patients

Reduced miR-128 in Breast Tumor-Initiating Cells Induces Chemotherapeutic Resistance via Bmi-1 and ABCC5

Enhancer-Driven lncRNA BDNF-AS Induces Endocrine Resistance and Malignant Progression of Breast Cancer through the RNH1/TRIM21/mTOR Cascade

Long noncoding RNA HOTAIR is a prognostic marker for esophageal squamous cell carcinoma progression and survival

MiR-196a promotes pancreatic cancer progression by targeting nuclear factor kappa-B-inhibitor alpha

Magnetic resonance imaging radiomics predicts preoperative axillary lymph node metastasis to support surgical decisions and is associated with tumor microenvironment in invasive breast cancer: A machine learning, multicenter study

Impact of body mass index and its change on survival outcomes in patients with early breast cancer: A pooled analysis of individual-level data from BCIRG-001 and BCIRG-005 trials

Overexpressed Cyclin D1 and CDK4 proteins are responsible for the resistance to CDK4/6 inhibitor in breast cancer that can be reversed by PI3K/mTOR inhibitors

Landscape of somatic alterations in large-scale solid tumors from an Asian population

Distinct ER and PR expression patterns significantly affect the clinical outcomes of early HER2-positive breast cancer: A real-world analysis of 871 patients treated with neoadjuvant therapy

The Overexpression of Hypomethylated miR-663 Induces Chemotherapy Resistance in Human Breast Cancer Cells by Targeting Heparin Sulfate Proteoglycan 2 (HSPG2)

Aktive Filter

Suchergebnisse filtern